Cord blood transplants offer hope for kids without a donor match

NCT ID NCT04644016

Recruiting now Disease control Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a cord blood transplant in children and young adults (up to age 21) with life-threatening blood cancers or non-cancer blood disorders who do not have a matched family donor. The goal is to see if this approach lowers the risk of death from treatment one year after transplant. Participants receive a myeloablative (high-dose) conditioning regimen before the transplant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia acute myeloid leukemia Bone Marrow Failure Disorders bone marrow failure syndrome hemoglobinopathy hemophagocytic syndrome inborn errors of metabolism inherited hemoglobinopathy myelodysplastic syndrome myelodysplastic syndrome with excess blasts Myeloproliferative Disorders non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALL AML BONE MARROW FAILURE HEMOGLOBINOPATHIES HLH INHERITED METABOLIC DISORDERS MDS MPD WITHOU MYELOFIBROSIS NHL OR HL

Contacts and locations

Locations

Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.